TTR and cardiac amyloidosis: TTR stabilizing therapy (tafamidis) was the most frequently reported among the specific treatments for this disease, although it was used by a very low, because unfortunately, in Brazil, the use of tafamidis for patients with cardiac amyloidosis was not approved by government agencies.